Annis Gardner Whiting Capital Advisors, LLC Gilead Sciences, Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $236 Billion
- Q1 2025
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 361 shares of GILD stock, worth $39,738. This represents 0.02% of its overall portfolio holdings.
Number of Shares
361
Previous 352
2.56%
Holding current value
$39,738
Previous $32.5 Million
24.41%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,286Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.9 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.55 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.01 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.89 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...